Related Experiment Video
Updated: Mar 9, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.2K
Interventions to improve adherence to lipid-lowering medication.
Mieke L van Driel1,2, Michael D Morledge3, Robin Ulep3
1Discipline of General Practice, School of Medicine, The University of Queensland, Brisbane, Queensland, Australia, 4029.
The Cochrane Database of Systematic Reviews
|December 22, 2016
Summary
Intensified patient care interventions significantly improve adherence to lipid-lowering medications and lower cholesterol levels. These strategies enhance medication adherence for better cardiovascular health outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Lipid-lowering drugs are underutilized despite proven cardiovascular benefits.
- Poor patient adherence negatively impacts the effectiveness of lipid-lowering treatments.
Purpose of the Study:
- To evaluate interventions designed to enhance adherence to lipid-lowering medications.
- To assess the impact of these interventions on adherence rates and clinical outcomes.
Main Methods:
- Systematic review and meta-analysis of 35 randomized controlled trials involving 925,171 participants.
- Searched multiple databases including CENTRAL, MEDLINE, Embase, PsycINFO, and CINAHL.
- Assessed study quality using the Cochrane Handbook and GRADEPro.
Main Results:
- Intensified patient care interventions improved short-term adherence (OR 1.93) and long-term adherence (OR 2.87).
- Significant reductions in total cholesterol and LDL-cholesterol were observed with intensified interventions.
- Moderate to high-quality evidence supports the effectiveness of these interventions.
Conclusions:
- Interventions intensifying patient care effectively improve medication adherence and lipid levels.
- Healthcare systems can leverage team-based approaches to boost adherence to lipid-lowering medicines.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
01:26Atherosclerosis III: Management
541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
01:27Bioavailability Enhancement: Drug Permeability Enhancement
283
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
283
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
799
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
799
01:26Coronary Artery Disease IV: Preventive Measures
789
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
01:27Peripheral Artery Disease III: Interprofessional Care
472
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
472